Pilulka Lekarny ASXPRA:PINK -0.43%49 Current Ratio is 0.63 as of Dec. 2025, which is 7% below its 10-year median of 0.68. GuruFocus rates XPRA:PINK with a GF Score™ of 49/100 and a GF Value™ of Kč113.86 (Fairly Valued). The stock has 6 warning signs investors should review. Among 678 Healthcare Providers & Services companies, Pilulka Lekarny AS ranks worse than 87.46% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Pilulka Lekarny AS's current ratio for the quarter that ended in Dec. 2025 was 0.63.
Pilulka Lekarny AS has a current ratio of 0.63. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If Pilulka Lekarny AS has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.
The historical rank and industry rank for Pilulka Lekarny AS's Current Ratio or its related term are showing as below:
XPRA:PINK'
s Current Ratio Range Over the Past 10 Years
Min: 0.45 Med: 0.68 Max: 0.93
Current: 0.63
During the past 6 years, Pilulka Lekarny AS's highest Current Ratio was 0.93. The lowest was 0.45. And the median was 0.68.
XPRA:PINK's Current Ratio is ranked worse than 87.46% of 678
companies
in the Healthcare Providers & Services industry
Industry Median: 1.475
vs XPRA:PINK: 0.63
Pilulka Lekarny AS (XPRA:PINK) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Pilulka Lekarny AS Current Ratio Related Terms
Pilulka Lekarny AS Current Ratio Historical Data
* Premium members only.
The historical data trend for Pilulka Lekarny AS's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pilulka Lekarny AS Current Ratio Competitor Comparison
For the Pharmaceutical Retailers subindustry, Pilulka Lekarny AS's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pilulka Lekarny AS Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pilulka Lekarny AS's Current Ratio distribution charts can be found below:
* The bar in red indicates where Pilulka Lekarny AS's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pilulka Lekarny AS (XPRA:PINK) has a Current Ratio of 0.63 as of Dec. 2025. This is near median its historical median of 0.68. Over the past decade, Pilulka Lekarny AS's Current Ratio has ranged from 0.45 to 0.93. According to the industry distribution chart, Pilulka Lekarny AS ranks #593 out of 678 companies in the Healthcare Providers & Services industry, placing it in the top 87.5%.
Is Pilulka Lekarny AS's Current Ratio too high?
Pilulka Lekarny AS's current Current Ratio of 0.63 is near median its 10-year median of 0.68. Over the past 10 years, this metric has ranged from a low of 0.45 to a high of 0.93. The Healthcare Providers & Services industry median Current Ratio is 1.48. Pilulka Lekarny AS's value of 0.63 is 57.3% below this industry median. Based on the distribution chart, Pilulka Lekarny AS ranks #593 out of 678 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Pilulka Lekarny AS has a GF Score™ of 49/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pilulka Lekarny AS's Current Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Pilulka Lekarny AS ranks #593 out of 678 companies for Current Ratio. This places Pilulka Lekarny AS in the lower half of its industry. The industry median Current Ratio is 1.48. Pilulka Lekarny AS's value of 0.63 is 57.3% below this benchmark. Historically, Pilulka Lekarny AS's own Current Ratio has ranged from 0.45 to 0.93 over the past decade. While the company's 10-year median is 0.68 vs. the industry median of 1.48, Pilulka Lekarny AS has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.48, based on 678 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pilulka Lekarny AS's current Current Ratio of 0.63 is 57.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pilulka Lekarny AS's current Current Ratio is 0.63, which is near median its own 10-year median of 0.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pilulka Lekarny AS stock overvalued right now?
Based on GuruFocus' analysis, Pilulka Lekarny AS (XPRA:PINK) is currently considered Fairly Valued. The stock's GF Value™ is Kč113.86, compared to a current price of Kč114.50 — trading 0.6% above its estimated fair value. The current Current Ratio is 0.63, which is near median its 10-year median of 0.68 and 57.3% below the Healthcare Providers & Services industry median of 1.48. Pilulka Lekarny AS's overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Pilulka Lekarny AS (XPRA:PINK), the current Current Ratio is 0.63 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pilulka Lekarny AS (XPRA:PINK) Overvalued in 2026?
Based on GuruFocus' analysis, Pilulka Lekarny AS stock appears to be overvalued.
The current stock price of Kč114.50 is trading 0.6% above its estimated GF Value™ of Kč113.86.
GuruFocus considers Pilulka Lekarny AS to be Fairly Valued.
Key valuation signals for XPRA:PINK:
Current Ratio: 0.63 (near median its 10-year median of 0.68)
GF Value™: Kč113.86 vs. price of Kč114.50 (0.6% above fair value)
Industry Position: 57.3% below the Healthcare Providers & Services median (#593 of 678)
No single metric tells the full story. See the XPRA:PINK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pilulka Lekarny AS operates an online pharmaceutical store by distribution of medicinal products. The store offers over-the-counter-drugs, dietary supplements, baby foods, mother care products, cosmetics, other prescription drugs, sport nutritional products, diagnostic test kits, orthopaedic supplies, first aid kits, and other related products.
49GF Score
Get the complete analysis for XPRA:PINK
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPRA:PINK has been successfully added to your 